Most studies have focused on patients with early-stage NSCLC (stage I–III), and a meta-analysis have shown that high Ki-67 index predicts worse DFS and OS in patients with early-stage NSCLC (Xu et al. 2019). The gene discussed is MKI67; the disease is non-small cell lung carcinoma.